期刊文献+

抗柯萨奇病毒A组2型单克隆抗体制备及ELISA抗原检测方法的建立

Generation of anti-coxsackievirus A2 monoclonal antibodies and establishment of quantitative antigen ELISA
原文传递
导出
摘要 目的制备抗柯萨奇病毒A组2型(coxsackievirus A2,CV-A2)单克隆抗体(单抗),建立CV-A2抗原检测方法。方法用纯化后的CV-A2全病毒颗粒免疫小鼠,筛选获得抗CV-A2单抗。建立CV-A2抗原检测方法,确定线性范围,对其准确度、精密度、稳定性、专属性进行验证。用ELISA检测病毒颗粒纯化过程中样品的抗原含量。结果制备了高效价的抗CV-A2单抗并建立ELISA抗原检测方法,检测范围为5.00~320.00 ng/ml。高、中、低3个浓度样品准确度验证回收率在89.58%~104.78%之间。重复性验证变异系数分别为2.10%、2.47%、6.18%。中间精密度验证变异系数分别为2.89%、2.69%、1.94%。耐用性验证回收率在84.26%~114.21%之间。包被微孔板于37℃放置3 d,样品回收率在90.31%~103.11%之间。专属性验证结果显示该方法只识别CV-A2抗原,与其他抗原均无交叉反应。结论建立并验证了CV-A2 ELISA抗原检测方法,可应用于病毒纯化过程中样品的抗原检测,还可应用于含CV-A2的手足口病多价疫苗的CV-A2抗原含量检测。 Objective To generate monoclonal antibodies(mAbs)against coxsackievirus A2(CV-A2)and to establish a quantitative antigen ELISA.Methods Mice were immunized by purified CV-A2 virions to obtain hybridomas secreting anti-CV-A2 mAbs.Linear range of established CV-A2 ELISA was determined,and its accuracy,precision,stability and specificity were validated.Samples in all purification steps of CV-A2 particles were detected.Results High binding-efficiency mAbs against CV-A2 were generated.A quantitative ELISA for antigen detection was established.The detection range was 5.00-320.00 ng/ml.The recovery rates for accuracy verification of samples with high,medium and low concentrations were between 89.58%and 104.78%.Their respective coefficients of variation(CVs)of repeatability verification were 2.10%,2.47%and 6.18%,and CVs of intermediate precision verification were 2.89%,2.69%and 1.94%.The recovery rates of durability were 84.26%-114.21%.Coated microtiter plate was placed at 37℃for 3 d and samples recovery rates were 90.31%-103.11%.Specificity verification showed that the method only recognized CV-A2 antigen,and did not cross react with other antigens.Conclusion A CV-A2 quantitative ELISA is established,which can be applied to antigen detection in samples at different purification stages of CV-A2,and in multivalent hand-foot-mouth disease vaccines containing CV-A2.
作者 吕诗韵 刘睿伦 杨志辉 吴杰 王文辉 申硕 Lyu Shiyun;Liu Ruilun;Yang Zhihui;Wu Jie;Wang Wenhui;Shen Shuo(Laboratory 1 of Viral Vaccine,Wuhan Institute of Biological Products Co.,Ltd.,National Engineering Technology Research Center of Combined Vaccines,Wuhan 430207,China)
出处 《国际生物制品学杂志》 CAS 2022年第2期90-96,共7页 International Journal of Biologicals
基金 国家科技重大专项"重大新药创制"(2015ZX09102021) 2017湖北省技术创新专项(2017ACA078)。
关键词 柯萨奇病毒 抗体 单克隆 双抗体夹心酶联免疫吸附测定 抗原 Coxsackievirus Antibodies,monoclonal Dual-antibody sandwich enzyme-linked immunosorbent assay Antigens
  • 相关文献

参考文献6

二级参考文献41

  • 1孙毅,靳艳,黄卫东,刘纯义,张萍.肠道病毒脑炎39例病原学及影响其预后的相关因素分析[J].中国小儿急救医学,2006,13(2):154-155. 被引量:15
  • 2侯文俊,杨健洋,胡燕,孙颖,貌盼勇.人类肠道病毒分子生物学分型鉴定方法的建立及应用[J].中华实验和临床病毒学杂志,2006,20(2):69-71. 被引量:9
  • 3柯昌文,王珣章.人肠道病毒分类和鉴别方法研究进展[J].中国计划免疫,2006,12(6):515-520. 被引量:19
  • 4中华人民共和国国家卫生和计划生育委员会.2014年度全国法定传染病疫情情况[EB/OL].[2015-02-25].http://www.moh.gov.en/jkj/s3578/201502/847e041a3bae4e3e844f17309beOeabd.shtml.
  • 5Xing W,Liao Q,Viboud C,et al.Hand,foot,and mouth disease in China,2008-12:an epidemiological study[J].Lancet Infect Dis,2014,14(4):308-318.
  • 6Wu G,Zhu W,Gao Y,et a1.The risk factors of hand-foot-mouth disease in Chinese Mainland people[J].Indian J Pediatr,2014,81(12):1420-1429.
  • 7Chong P,Liu CC,Chow YH,et al.Review of enterovirus 71 vaccines[J].Clin Infect Dis,2015,60(5):797-803.
  • 8Lee MS,Chiang PS,Luo ST,et al.Incidence rates of enterovirus71 infections in young children in Taiwan,2008-2009[J].PLo S Negl Trop Dis,2012,6(2):e1476-e1491.
  • 9Liang Z,Mao Q,Gao F,et al.Progress on the research and development of human enterovirus 71(EV71)vaccines[J].Front Med,2013,9(8):1701-1705.
  • 10Liang Z,Wang J.EV71 vaccine,an invaluable gift for children[J].Clin Transl Immunology,2014,3(10):e28-e31.

共引文献211

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部